Toward Personalized Transfusion Strategies: The Emerging Role of Wearable Biosensors in Chronic Anemia Management [0.03%]
迈向个性化输血策略：可穿戴生物传感器在慢性贫血管理中的新兴作用
R P B Tonino,M R Schipperus,J J Zwaginga
R P B Tonino
Chronic transfusion-dependent anemia presents ongoing challenges in optimizing symptom control and functional outcomes, particularly in an older, often comorbid patient group. Conventional transfusion strategies based on fixed hemoglobin th...
ABO matching for platelet transfusions for prevention or treatment of bleeding: A systematic review with meta-analysis [0.03%]
一种系统性回顾与meta分析：ABO同型输注血小板预防或治疗出血事件的有效性
Lorna Cain,Asha Aggarwal,Louise J Geneen et al.
Lorna Cain et al.
Transfusion of ABO identical platelets is recommended in national guidelines, though transfusion of ABO non-identical platelets has been widely adopted to ensure availability and reduce wastage. When ABO non-identical platelets are necessit...
Artificial Intelligence and Machine Learning in Transfusion Practice: An Analytical Assessment [0.03%]
输血实践中的人工智能与机器学习：一项分析评估
Na Li,Ruchika Goel,Sheharyar Raza et al.
Na Li et al.
Transfusion medicine is vital to healthcare and affects clinical outcomes, patient safety, and system resilience while addressing challenges such as blood shortages, donor variability, and rising costs. The integration of artificial intelli...
Analytical Review: Neutrophil Extracellular Traps and Antiphospholipid syndrome [0.03%]
分析评论：中性粒细胞胞外陷阱和抗磷脂综合征
Ayesha Butt,Anish Sharda,Alfred Ian Lee et al.
Ayesha Butt et al.
Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disorder defined by the presence of one or more antiphospholipid antibodies (aPL) in conjunction with clinical manifestations such as thrombosis and/or obstetrical complications...
Ultra-Restrictive Transfusion Thresholds in Critically Ill Adults: Perhaps Not for Everyone [0.03%]
重症成人超限制性输血阈值：或许并不适合所有人
Orlando Rubén Pérez-Nieto,Ignacio Rodríguez-Guevara,Rafael Alfonso Reyes-Monge et al.
Orlando Rubén Pérez-Nieto et al.
Quantifying Harms Associated With Red Cell ABO Incompatible Blood Transfusion: A Systematic Review of the UK SHOT Literature [0.03%]
基于英国SHOT文献回顾的红细胞ABO不相容输血危害的量化分析系统回顾
Florence Oyekan,Helinor McAleese,Montasir Ahmed et al.
Florence Oyekan et al.
ABO-incompatible (ABOi) red blood cell (RBC) transfusions can lead to severe clinical consequences, including patient death. Electronic systems, such as Bedside Electronic Transfusion Checks (BETC), have been developed to lower the risk of ...
Optimizing Buffy Coat Pooling: Enhancing Platelet Yield Through Platelet Count-Based Sorting [0.03%]
基于计数的血小板分选优化 Buffy Coat 分离提高血小板产量
Marco Amato,Manfred Astl,Lisa Seekircher et al.
Marco Amato et al.
Optimizing platelet yield in pooled buffy coat (BC)-derived platelet products by sorting them according to donor whole blood (WB) platelet counts is a promising approach to increase the production of double-dose platelet concentrates while ...
Intravenous Iron Therapy Versus Blood Transfusion for Iron Deficiency Anemia: A Systematic Review [0.03%]
缺铁性贫血患者静脉注射补铁与输血治疗效果的系统评价研究
Martin Bedan,Christian Lottrup
Martin Bedan
This systematic review aimed to assess and compare the effect of blood transfusion and intravenous iron therapy on the hemoglobin levels based on clinical trials. To do this, a search was conducted 25th of September 2024 by using PubMed, Co...
Combinations of Non-di(2-ethylhexyl) Phthalate Collection Sets, Storage Bags and Additive Solutions for Red Blood Cells [0.03%]
非邻苯二甲酸二辛酯血袋添加剂及组合使用对红细胞质量的影响
Stefan F van Wonderen,Christie Vermeulen,Johan Lagerberg et al.
Stefan F van Wonderen et al.
For decades, di(2-ethylhexyl) phthalate (DEHP) has been the primary plasticizer used to make polyvinyl chloride (PVC) blood bags flexible. DEHP leaches into the blood product, stabilizing red blood cell (RBC) membranes and preventing excess...
Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis [0.03%]
识别CAR-T细胞治疗有效性和安全性的调节因素：系统评价和个体患者数据的荟萃分析
Manoj M Lalu,Samuel Igweokpala,Natasha Kekre et al.
Manoj M Lalu et al.
CAR T-cell therapy is effective in relapsed/refractory hematologic malignancies, but its use has been tempered by heterogeneity in response and safety outcomes. We performed individual patient data meta-analysis (IPDMA) of CAR T-cell therap...